NCT00080041View on ClinicalTrials.gov

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions
Breast NeoplasmsOvarian NeoplasmsProstatic NeoplasmsLung Neoplasms
Interventions
DRUG

Motexafin Gadolinium Injection

Trial Locations (1)

Unknown

University of Rochester Cancer Center, Rochester

Sponsors

Lead Sponsor

Pharmacyclics LLC.
All Listed Sponsors
lead

Pharmacyclics LLC.

INDUSTRY

NCT00080041 - Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors | Biotech Hunter | Biotech Hunter